Revenue
$1.67B
Fiscal year ended 2026-03-31Operating income
Unavailable
Fiscal year ended 2026-03-31Free cash flow
-$165.00M
Fiscal year ended 2026-03-31CLOROX CO /DE/ (CLX) reported revenue of $1.67B and net income of $187.00M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CLOROX CO /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.67B | $1.43B | $1.99B | $1.67B | $1.69B | $1.76B | $1.90B | $1.81B | $1.99B |
| Cost of revenue | $948.00M | $951.00M | $833.00M | $1.06B | $924.00M | $948.00M | $955.00M | $1.02B | $1.05B | $1.12B |
| Gross profit | $722.00M | $722.00M | $596.00M | $924.00M | $744.00M | $738.00M | $807.00M | $884.00M | $766.00M | $866.00M |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | $187.00M | $157.00M | $80.00M | $332.00M | $186.00M | $193.00M | $99.00M | $216.00M | -$51.00M | $93.00M |
| Research & development | $27.00M | $29.00M | $28.00M | $32.00M | $27.00M | $31.00M | $31.00M | $33.00M | $32.00M | $32.00M |
| Weighted-average diluted shares | shares 121.79M | shares 121.92M | shares 123.02M | Unavailable | shares 124.07M | shares 124.66M | shares 124.68M | Unavailable | shares 124.25M | shares 124.62M |
| Pretax income | $256.00M | $215.00M | $107.00M | $410.00M | $254.00M | $237.00M | $177.00M | $275.00M | -$42.00M | $136.00M |
| Income tax expense | $65.00M | $54.00M | $25.00M | $74.00M | $63.00M | $43.00M | $74.00M | $54.00M | $8.00M | $40.00M |
| Diluted EPS | $1.54 | $1.29 | $0.65 | Unavailable | $1.50 | $1.54 | $0.80 | Unavailable | $-0.41 | $0.75 |
| Selling, general & administrative | $229.00M | $262.00M | $277.00M | $296.00M | $267.00M | $280.00M | $281.00M | $268.00M | $301.00M | $322.00M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.19B | $227.00M | $166.00M | $167.00M | $226.00M | $290.00M | $278.00M | $202.00M | $219.00M | $355.00M |
| Total assets | $6.44B | $5.61B | $5.53B | $5.56B | $5.51B | $5.58B | $5.50B | $5.75B | $5.80B | $5.91B |
| Current assets | $2.65B | $1.73B | $1.70B | $1.61B | $1.59B | $1.63B | $1.58B | $1.62B | $1.66B | $1.80B |
| Total liabilities | $6.34B | $5.58B | $5.39B | $5.08B | $5.32B | $5.46B | $5.27B | $5.26B | $5.55B | $5.69B |
| Current liabilities | $3.16B | $2.35B | $2.23B | $1.92B | $2.16B | $1.73B | $1.58B | $1.57B | $1.85B | $2.02B |
| Total equity incl. NCI | $92.00M | $35.00M | $138.00M | $482.00M | $190.00M | $121.00M | $224.00M | $492.00M | $255.00M | $218.00M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $588.00M | $608.00M | $577.00M | $523.00M | $635.00M | $592.00M | $594.00M | $637.00M | $674.00M | $655.00M |
| Accounts receivable | $671.00M | $671.00M | $703.00M | $821.00M | $597.00M | $603.00M | $595.00M | $695.00M | $673.00M | $679.00M |
| Goodwill | $1.23B | $1.23B | $1.23B | $1.23B | $1.22B | $1.22B | $1.23B | $1.23B | $1.23B | $1.25B |
| Long-term debt | $2.49B | $2.49B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B | $2.48B |
| Accounts payable | Unavailable | Unavailable | Unavailable | $838.00M | Unavailable | Unavailable | Unavailable | $950.00M | Unavailable | Unavailable |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$122.00M | $311.00M | $93.00M | $294.00M | $286.00M | $180.00M | $221.00M | $340.00M | $182.00M | $153.00M |
| Capital expenditures | $43.00M | $42.00M | $36.00M | $75.00M | $53.00M | $53.00M | $39.00M | $81.00M | $55.00M | $52.00M |
| Investing cash flow | -$43.00M | -$43.00M | -$34.00M | -$76.00M | -$53.00M | -$54.00M | $89.00M | -$81.00M | -$38.00M | -$33.00M |
| Financing cash flow | $1.13B | -$210.00M | -$59.00M | -$279.00M | -$299.00M | -$109.00M | -$237.00M | -$273.00M | -$278.00M | -$259.00M |
| Net change in cash | $958.00M | $60.00M | -$1.00M | -$59.00M | -$65.00M | $12.00M | $75.00M | -$14.00M | -$137.00M | -$162.00M |
| Stock-based compensation | $15.00M | $24.00M | $10.00M | $17.00M | $24.00M | $27.00M | $13.00M | $19.00M | $26.00M | $16.00M |
| Common dividends paid | $150.00M | $151.00M | $151.00M | $150.00M | $150.00M | $151.00M | $151.00M | $149.00M | $148.00M | $149.00M |
| Common share repurchases | $0 | $127.00M | $129.00M | $75.00M | $0 | $150.00M | $107.00M | $0 | $0 | $0 |
| Depreciation & amortization | $58.00M | $55.00M | $56.00M | $57.00M | $55.00M | $53.00M | $54.00M | $59.00M | $58.00M | $57.00M |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$165.00M | $269.00M | $57.00M | $219.00M | $233.00M | $127.00M | $182.00M | $259.00M | $127.00M | $101.00M |
| Gross margin | 43.2% | 43.2% | 41.7% | 46.5% | 44.6% | 43.8% | 45.8% | 46.5% | 42.2% | 43.5% |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | -9.9% | 16.1% | 4.0% | 11.0% | 14.0% | 7.5% | 10.3% | 13.6% | 7.0% | 5.1% |
| SBC / revenue | 0.9% | 1.4% | 0.7% | 0.9% | 1.4% | 1.6% | 0.7% | 1.0% | 1.4% | 0.8% |
| Current ratio | 0.84x | 0.74x | 0.76x | 0.84x | 0.74x | 0.94x | 1.00x | 1.03x | 0.90x | 0.89x |
| Revenue YoY growth | 0.1% | -0.8% | -18.9% | 4.5% | -8.0% | -15.3% | 27.1% | -5.7% | -5.3% | 16.0% |
| Net margin | 11.2% | 9.4% | 5.6% | 16.7% | 11.2% | 11.4% | 5.6% | 11.4% | -2.8% | 4.7% |
| R&D / revenue | 1.6% | 1.7% | 2.0% | 1.6% | 1.6% | 1.8% | 1.8% | 1.7% | 1.8% | 1.6% |
| CapEx / revenue | 2.6% | 2.5% | 2.5% | 3.8% | 3.2% | 3.1% | 2.2% | 4.3% | 3.0% | 2.6% |
| Long-term debt / equity | 27.03x | Unavailable | Unavailable | 5.15x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 25.4% | 25.1% | 23.4% | 18.0% | 24.8% | 18.1% | 41.8% | 19.6% | Unavailable | 29.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-30View SEC filing
10-Q · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-11-03View SEC filing
10-K · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-05View SEC filing
10-Q · Filed 2025-02-03View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.